Related references
Note: Only part of the references are listed.Re-evaluating the effect of Favipiravir treatment on rabies virus infection
Ashley C. Banyard et al.
VACCINE (2019)
Combination therapy of rabies-infected mice with inhibitors of pro-inflammatory host response, antiviral compounds and human rabies immunoglobulin
Andras Marosi et al.
VACCINE (2019)
Screening and evaluation of potential inhibitors against vaccinia virus from 767 approved drugs
Jiajing Wu et al.
JOURNAL OF MEDICAL VIROLOGY (2019)
Reevaluation of the efficacy of favipiravir against rabies virus using in vivo imaging analysis
Kentaro Yamada et al.
ANTIVIRAL RESEARCH (2019)
Ribavirin-related compounds exert in vitro inhibitory effects toward rabies virus
Paulina D. Anindita et al.
ANTIVIRAL RESEARCH (2018)
The Physicochemical Basis of Clofazimine-Induced Skin Pigmentation
Mikhail D. Murashov et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Screening of FDA-Approved Drugs for Inhibitors of Japanese Encephalitis Virus Infection
Shaobo Wang et al.
JOURNAL OF VIROLOGY (2017)
Rabies
Anthony R. Fooks et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Development of in vitro and in vivo rabies virus neutralization assays based on a high-titer pseudovirus system
Jianhui Nie et al.
SCIENTIFIC REPORTS (2017)
Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis
Kentaro Yamada et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Screening of a Library of FDA-Approved Drugs Identifies Several Enterovirus Replication Inhibitors That Target Viral Protein 2C
Rachel Ulferts et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
T-705 as a Potential Therapeutic Agent for Rabies
Phatthamon Virojanapirom et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
State-dependent blocking mechanism of Kv1.3 channels by the antimycobacterial drug clofazimine
Malika Faouzi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Everything You Always Wanted to Know About Rabies Virus (But Were Afraid to Ask)
Benjamin M. Davis et al.
ANNUAL REVIEW OF VIROLOGY, VOL 2 (2015)
RDIS: The Rabies Disease Information System
Baskeran Dharmalingam et al.
BIOINFORMATION (2015)
Correlation between Potassium Channel Expression and Sensitivity to Drug-induced Cell Death in Tumor Cell Lines
Luigi Leanza et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Current status of rabies and prospects for elimination
Anthony R. Fooks et al.
LANCET (2014)
Favipiravir elicits antiviral mutagenesis during virus replication in vivo
Armando Arias et al.
ELIFE (2014)
Current and future approaches to the therapy of human rabies
Alan C. Jackson
ANTIVIRAL RESEARCH (2013)
Clofazimine: current status and future prospects
Moloko C. Cholo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Systematic Evaluation of Structure-Activity Relationships of the Riminophenazine Class and Discovery of a C2 Pyridylamino Series for the Treatment of Multidrug-Resistant Tuberculosis
Binna Liu et al.
MOLECULES (2012)
Clofazimine Analogs with Efficacy against Experimental Tuberculosis and Reduced Potential for Accumulation
Yu Lu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Rabies virus infection of primary neuronal cultures and adult mice: Failure to demonstrate evidence of excitotoxicity
Simon C. Weli et al.
JOURNAL OF VIROLOGY (2006)
QRAR Models for Central Nervous System Drugs using Biopartitioning Micellar Chromatography
C. Quinones-Torrelo et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2002)
In vitro prediction of gastrointestinal absorption and bioavailability: an experts' meeting report
O Pelkonen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Share Paper
